Meyer AH - Search Results

1

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

Delille HK, Becker JM, Burkhardt S, Bleher B, Terstappen GC, Schmidt M, Meyer AH, Unger L, Marek GJ, Mezler M. Delille HK, et al. Among authors: meyer ah. Neuropharmacology. 2012 Jun;62(7):2184-91. doi: 10.1016/j.neuropharm.2012.01.010. Epub 2012 Jan 25. Neuropharmacology. 2012. PMID: 22300836

2

LIM-only protein 4 interacts directly with the repulsive guidance molecule A receptor Neogenin.

Schaffar G, Taniguchi J, Brodbeck T, Meyer AH, Schmidt M, Yamashita T, Mueller BK. Schaffar G, et al. Among authors: meyer ah. J Neurochem. 2008 Oct;107(2):418-31. doi: 10.1111/j.1471-4159.2008.05621.x. Epub 2008 Aug 12. J Neurochem. 2008. PMID: 18702663 Free article.

3

Brain delivery research in public-private partnerships: The IMI-JU COMPACT consortium as an example.

Meyer AH, Untucht C, Terstappen GC. Meyer AH, et al. Neuropharmacology. 2017 Jul 1;120:8-10. doi: 10.1016/j.neuropharm.2016.06.012. Epub 2016 Jun 16. Neuropharmacology. 2017. PMID: 27318272 Review.

4

Strategies for delivering therapeutics across the blood-brain barrier.

Terstappen GC, Meyer AH, Bell RD, Zhang W. Terstappen GC, et al. Among authors: meyer ah. Nat Rev Drug Discov. 2021 May;20(5):362-383. doi: 10.1038/s41573-021-00139-y. Epub 2021 Mar 1. Nat Rev Drug Discov. 2021. PMID: 33649582 Review.

5

Trafficking of JC virus-like particles across the blood-brain barrier.

Ye D, Zimmermann T, Demina V, Sotnikov S, Ried CL, Rahn H, Stapf M, Untucht C, Rohe M, Terstappen GC, Wicke K, Mezler M, Manninga H, Meyer AH. Ye D, et al. Among authors: meyer ah. Nanoscale Adv. 2021 Feb 9;3(9):2488-2500. doi: 10.1039/d0na00879f. eCollection 2021 May 4. Nanoscale Adv. 2021. PMID: 36134165 Free PMC article.

6

Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery.

Meyer AH, Feldsien TM, Mezler M, Untucht C, Venugopalan R, Lefebvre DR. Meyer AH, et al. Pharmaceutics. 2023 Mar 29;15(4):1100. doi: 10.3390/pharmaceutics15041100. Pharmaceutics. 2023. PMID: 37111587 Free PMC article. Review.

7

A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse.

Brederson JD, Strakhova M, Mills C, Barlow E, Meyer A, Nimmrich V, Leddy M, Simler G, Schmidt M, Jarvis M, Lacy S. Brederson JD, et al. Eur J Pain. 2016 Apr;20(4):607-14. doi: 10.1002/ejp.775. Epub 2015 Sep 22. Eur J Pain. 2016. PMID: 26392119

8

Targeting blood-brain-barrier transcytosis - perspectives for drug delivery.

Mäger I, Meyer AH, Li J, Lenter M, Hildebrandt T, Leparc G, Wood MJA. Mäger I, et al. Among authors: meyer ah. Neuropharmacology. 2017 Jul 1;120:4-7. doi: 10.1016/j.neuropharm.2016.08.025. Epub 2016 Aug 22. Neuropharmacology. 2017. PMID: 27561970 Free article. Review.

9

Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis.

Demicheva E, Cui YF, Bardwell P, Barghorn S, Kron M, Meyer AH, Schmidt M, Gerlach B, Leddy M, Barlow E, O'Connor E, Choi CH, Huang L, Veldman GM, Rus H, Shabanzadeh AP, Tassew NG, Monnier PP, Müller T, Calabresi PA, Schoemaker H, Mueller BK. Demicheva E, et al. Among authors: meyer ah. Cell Rep. 2015 Mar 24;10(11):1887-98. doi: 10.1016/j.celrep.2015.02.048. Cell Rep. 2015. PMID: 25801027 Free article.

10

Laser capture microdissection and microarray analysis of dividing neural progenitor cells from the adult rat hippocampus.

Gurok U, Loebbert RW, Meyer AH, Mueller R, Schoemaker H, Gross G, Behl B. Gurok U, et al. Among authors: meyer ah. Eur J Neurosci. 2007 Sep;26(5):1079-90. doi: 10.1111/j.1460-9568.2007.05734.x. Eur J Neurosci. 2007. PMID: 17767487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page